↓ Skip to main content

American Association for Cancer Research

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Overview of attention for article published in Clinical Cancer Research, November 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
14 news outlets
blogs
1 blog
twitter
45 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
29 Mendeley